These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study. Asteria CR; Ficari F; Bagnoli S; Milla M; Tonelli F Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of an MRI-based score of disease activity in perianal fistulizing Crohn's disease. Horsthuis K; Ziech ML; Bipat S; Spijkerboer AM; de Bruine-Dobben AC; Hommes DW; Stoker J Clin Imaging; 2011; 35(5):360-5. PubMed ID: 21872125 [TBL] [Abstract][Full Text] [Related]
12. Long-term partial remission of autoimmune thrombocytopenia in a patient treated with the anti-tumor necrosis factor-alpha antibody infliximab for refractory fistulizing Crohn's disease. de Rossi TM; Krauss N; Voll RE; Nägel A; Weidenhiller M; Konturek PC; Hahn EG; Raithel M Digestion; 2008; 78(4):195-200. PubMed ID: 19122456 [TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of infliximab combined with surgery for perianal fistulizing Crohn's disease. Yang BL; Chen YG; Gu YF; Chen HJ; Sun GD; Zhu P; Shao WJ World J Gastroenterol; 2015 Feb; 21(8):2475-82. PubMed ID: 25741157 [TBL] [Abstract][Full Text] [Related]
14. [Efficacy of infliximab combined with surgery in the treatment of perianal fistulizing Crohn disease]. Yang BL; Lin Q; Chen HJ; Sun GD; Zhu P; Chen YQ; Gu YF Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Apr; 16(4):323-7. PubMed ID: 23608791 [TBL] [Abstract][Full Text] [Related]
17. Basic fibroblast growth factor as a response parameter to infliximab in fistulizing Crohn's disease. Gao Q; Hogezand RA; Lamers CB; Verspaget HW Aliment Pharmacol Ther; 2004 Sep; 20(5):585-92. PubMed ID: 15339330 [TBL] [Abstract][Full Text] [Related]
18. [Perianal fistulas in Crohn's disease--biologicals and surgery: is it worthwhile?]. Bode M; Eder S; Schürmann G Z Gastroenterol; 2008 Dec; 46(12):1376-83. PubMed ID: 19053007 [TBL] [Abstract][Full Text] [Related]
19. Anti-TNF-alpha (infliximab) used as induction treatment in case of active proctitis in a multistep strategy followed by definitive surgery of complex anal fistulas in Crohn's disease: a preliminary report. van der Hagen SJ; Baeten CG; Soeters PB; Russel MG; Beets-Tan RG; van Gemert WG Dis Colon Rectum; 2005 Apr; 48(4):758-67. PubMed ID: 15750797 [TBL] [Abstract][Full Text] [Related]
20. Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn's disease. Ochsenkühn T; Göke B; Sackmann M Am J Gastroenterol; 2002 Aug; 97(8):2022-5. PubMed ID: 12190171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]